Saturna Capital Corp Novo Nordisk A S Transaction History
Saturna Capital Corp
- $7.5 Billion
- Q3 2024
A detailed history of Saturna Capital Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Saturna Capital Corp holds 2,132,038 shares of NVO stock, worth $224 Million. This represents 3.38% of its overall portfolio holdings.
Number of Shares
2,132,038
Previous 2,136,005
0.19%
Holding current value
$224 Million
Previous $305 Million
16.74%
% of portfolio
3.38%
Previous 4.09%
Shares
26 transactions
Others Institutions Holding NVO
# of Institutions
1,954Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.12 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.51 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.51 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.4 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.28 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $237B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...